Open this publication in new window or tab >>Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;.
Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, Brazil;.
Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Inst Biol, Dept Biochem & Tissue Biol, Campinas, Brazil;.
Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil;.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Nutr Genom, BR-13484350 Limeira, SP, Brazil;;Univ Campinas UNICAMP, Obes & Comorbid Res Ctr, Campinas, Brazil;.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;;Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil;;Univ Campinas UNICAMP, Obes & Comorbid Res Ctr, Campinas, Brazil;.
Swedish School of Sport and Health Sciences, GIH, Department of Physiology, Nutrition and Biomechanics.
Univ Sao Paulo, Ribeirao Preto Med Sch, Postgrad Program Rehabil & Funct Performance, Ribeirao Preto, SP, Brazil;;Univ Sao Paulo, Sch Phys Educ & Sport Ribeirao Preto, Ribeirao Preto, SP, Brazil.
Univ Campinas UNICAMP, Sch Appl Sci, Lab Mol Biol Exercise LaBMEx, BR-13484350 Limeira, SP, Brazil;;Univ Estadual Campinas, Sch Appl Sci, Limeira, SP, Brazil;;Univ Campinas UNICAMP, Obes & Comorbid Res Ctr, Campinas, Brazil;.
Show others...
2025 (English)In: Molecular Metabolism, ISSN 2212-8778, Vol. 96, article id 102135Article in journal (Refereed) Published
Abstract [en]
Excessive exercise combined with inadequate recovery time may trigger fatigue, performance impairment, and ultimately the overtraining syndrome. The intramyocellular mechanisms involved in the overtraining syndrome remain only partially known. Here, we combined multi-omics analyses from isogenic BXD mouse strains with a mouse model of overtraining and excessive exercise protocol in mice and humans to evaluate the molecular mechanism involved in the performance impairment induced by excessive exercise. We identified that BXD mouse strains with elevated levels of Parp1 gene expression in the skeletal muscle displayed features like overtraining syndrome and abnormal muscle genetic signature. High PARP1 protein content and aberrant PARylation of proteins were detected in the skeletal muscle of overtrained, but not in trained mice. Overtraining syndrome reduced mitochondrial function promoted by exercise training, induced muscle hyperalgesia, reduced muscle fiber size and promoted a similar gene signature of myopathy and atrophy models. Short periods of excessive exercise also increased PARylation in the skeletal muscle of mice and healthy subjects. The pharmacological inhibition of PARP1, using Olaparib, and genetic Parp1 ablation, preserved muscle fiber morphology and protected against physical performance impairment and other symptoms of the overtraining syndrome in mice. In conclusion, PARP1 excessive activation is related to muscle abnormalities led by long or short periods of excessive exercise, and here we suggest that PARP1 is a potential target in the treatment and prevention of overtraining syndrome. (c) 2025 The Author(s). Published by Elsevier GmbH. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
Place, publisher, year, edition, pages
Elsevier, 2025
Keywords
Exercise, Muscle, PARP1, overtraining
National Category
Sport and Fitness Sciences Physiology and Anatomy
Research subject
Medicine/Technology
Identifiers
urn:nbn:se:gih:diva-8673 (URN)10.1016/j.molmet.2025.102135 (DOI)001470460600001 ()40187729 (PubMedID)2-s2.0-105002318754 (Scopus ID)
Note
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/)
2025-05-132025-05-132025-09-16